Fatty Acid Hydroxylase-associated Neurodegeneration (FAHN): A Patient Guide

Fatty Acid Hydroxylase-associated Neurodegeneration, commonly known as FAHN, is an ultra-rare genetic condition that fundamentally changes how the brain builds and maintains its protective wiring. As an autosomal recessive disorder, it occurs when a child inherits two changed copies of the FA2H gene—one from each parent—which reduces or alters the body’s ability to produce a specific enzyme essential for healthy nerves. This enzyme deficiency disrupts the maintenance of myelin, the insulation that allows the brain to send clear, rapid signals to the rest of the body. Without this protection, the nervous system faces a dual challenge: the white matter begins to deteriorate, and in many cases, iron may start to accumulate in the deep movement centers of the brain ^[1].

Because these changes affect the brain’s communication network, the symptoms usually emerge in early childhood and focus heavily on movement and coordination. Families often first notice a stiffness in the legs, known as spasticity, or a lack of balance called ataxia, which may look like frequent tripping or a shaky gait. As the condition progresses, it typically begins to affect other areas, including the clarity of speech, swallowing, and, in some instances, cognitive abilities. While FAHN is classified under the umbrella of Neurodegeneration with Brain Iron Accumulation (NBIA), it is important to understand that the “iron” part of the name can be misleading; many children do not show visible iron on an MRI for years, and its absence does not change the reality of the diagnosis ^[2][3].

FA2H-related disease exists on a spectrum. You may hear the condition referred to as spastic paraplegia type 35 (SPG35). FAHN and SPG35 are not separate look-alike diseases; they are overlapping names for the same disease spectrum caused by FA2H variants, with FAHN typically used when neurodegeneration and brain iron are more prominent, and SPG35 used when spasticity is the primary feature.

When doctors look at brain scans, they often search for a specific signature known as the WHAT pattern—a shorthand for changes in the white matter, signs of possible iron in the brain’s base, and the thinning or shrinking of certain brain structures. This descriptive pattern, along with clinical findings and molecular genetic testing, helps establish the diagnosis. Although the disease is progressive and there is currently no cure, identifying these markers early allows families to transition from the “diagnostic odyssey” of seeking answers to a proactive focus on management and support ^[1].

Living with FAHN requires a dedicated, multidisciplinary care team that looks at the child as a whole person rather than a collection of symptoms. This approach involves neurologists, physical and occupational therapists, speech-language pathologists, and specialists working together to manage muscle stiffness, support communication, and ensure proper nutrition. While the journey involves navigating significant physical changes, the goal of modern care is to maximize comfort, maintain independence for as long as possible, and provide the entire family with the emotional and medical resources needed to navigate the road ahead ^[4][5].